Peter Heeringa
TitleCited byYear
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
H Xiao, P Heeringa, P Hu, Z Liu, M Zhao, Y Aratani, N Maeda, RJ Falk, ...
The Journal of clinical investigation 110 (7), 955-963, 2002
10382002
Protective role of endothelial nitric oxide synthase
EWJA Albrecht, CA Stegeman, P Heeringa, RH Henning, H van Goor
The Journal of pathology 199 (1), 8-17, 2003
4592003
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies
H Xiao, A Schreiber, P Heeringa, RJ Falk, JC Jennette
The American journal of pathology 170 (1), 52-64, 2007
4052007
Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression
E Lutgens, M Gijbels, M Smook, P Heeringa, P Gotwals, VE Koteliansky, ...
Arteriosclerosis, thrombosis, and vascular biology 22 (6), 975-982, 2002
3752002
Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease
BS Van der Veen, MPJ de Winther, P Heeringa
Antioxidants & redox signaling 11 (11), 2899-2937, 2009
3152009
The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies
H Xiao, P Heeringa, Z Liu, D Huugen, P Hu, N Maeda, RJ Falk, ...
The American journal of pathology 167 (1), 39-45, 2005
2972005
Activation of granulocytes by anti‐neutrophil cytoplasmic antibodies (ANCA): a FcγRII‐dependent process
AHL Mulder, P Heeringa, H BROUWER, PC Limburg, ...
Clinical & Experimental Immunology 98 (2), 270-278, 1994
2421994
Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils
B de Vries, J Köhl, WKG Leclercq, TGAM Wolfs, AA van Bijnen, ...
The Journal of Immunology 170 (7), 3883-3889, 2003
2312003
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-α
D Huugen, H Xiao, A Van Esch, RJ Falk, CJ Peutz-Kootstra, WA Buurman, ...
The American journal of pathology 167 (1), 47-58, 2005
2202005
Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides
CGM Kallenberg, P Heeringa, CA Stegeman
Nature Reviews Rheumatology 2 (12), 661, 2006
2192006
Neutrophil activation in vitro and in vivo in Wegener's granulomatosis
E Brouwer, MG Huitema, AHL Mulder, P Heeringa, H van Goor, ...
Kidney international 45 (4), 1120-1131, 1994
2031994
Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice
D Huugen, A Van Esch, H Xiao, CJ Peutz-Kootstra, WA Buurman, ...
Kidney international 71 (7), 646-654, 2007
1902007
Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR−/− Mice
M Van Leeuwen, MJJ Gijbels, A Duijvestijn, M Smook, MJ van de Gaar, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (1), 84-89, 2008
1762008
Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis
A Rutgers, M Slot, P van Paassen, P van Breda Vriesman, P Heeringa, ...
American journal of kidney diseases 46 (2), 253-262, 2005
1742005
Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation1
B de Vries, RA Matthijsen, TGAM Wolfs, AA van Bijnen, P Heeringa, ...
Transplantation 75 (3), 375-382, 2003
1732003
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis
G Xing, M Chen, G Liu, P Heeringa, J Zhang, X Zheng, E Jie, ...
Journal of clinical immunology 29 (3), 282, 2009
1552009
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis
AJ Roth, JD Ooi, JJ Hess, MM Van Timmeren, EA Berg, CE Poulton, ...
The Journal of clinical investigation 123 (4), 1773-1783, 2013
1542013
Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype
E Kanters, MJJ Gijbels, I van der Made, MN Vergouwe, P Heeringa, ...
Blood 103 (3), 934-940, 2004
1302004
Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
W Annema, N Nijstad, M Tölle, JF de Boer, RVC Buijs, P Heeringa, ...
Journal of lipid research 51 (4), 743-754, 2010
1282010
Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.
P Heeringa, E Brouwer, PA Klok, MG Huitema, J Van Den Born, ...
The American journal of pathology 149 (5), 1695, 1996
1211996
The system can't perform the operation now. Try again later.
Articles 1–20